Free Trial

Vor Biopharma (VOR) Earnings Date, Estimates & Call Transcripts

Vor Biopharma logo
$0.16 -0.01 (-7.25%)
As of 05/13/2025 04:00 PM Eastern

Vor Biopharma Earnings Summary

Vor Biopharma posted Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.40, which hit the consensus estimate of -$0.40. With a trailing EPS of -$1.70, Vor Biopharma's earnings are expected to grow next year, from ($1.42) to ($1.03) per share.

Nov. 7 Earnings Resources

Consensus EPS
(Nov. 7)
-$0.40
Actual EPS
(Nov. 7)
-$0.40
Get Vor Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vor Biopharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

VOR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Vor Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.24-$0.24-$0.24
Q2 20251-$0.24-$0.24-$0.24
Q3 20251-$0.23-$0.23-$0.23
Q4 20251-$0.23-$0.23-$0.23
FY 2025 4 -$0.94 -$0.94 -$0.94
Q1 20261-$0.21-$0.21-$0.21
Q2 20261-$0.21-$0.21-$0.21
Q3 20261-$0.22-$0.22-$0.22
Q4 20261-$0.20-$0.20-$0.20

Vor Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/7/2024--$0.40-$0.40--$0.40--
8/8/2024--$0.41-$0.41--$0.41--
5/9/2024Q1 2024-$0.37-$0.45 -$0.08-$0.45--
3/20/2024Q4 2023-$0.49-$0.39+$0.10-$0.39--
11/7/2023Q3 2023-$0.46-$0.49 -$0.03-$0.49--
8/10/2023Q2 2023-$0.42-$0.45 -$0.03-$0.45--

Vor Biopharma Earnings - Frequently Asked Questions

Vor Biopharma (NYSE:VOR) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on VOR's earnings history.

In the previous quarter, Vor Biopharma (NYSE:VOR) reported ($0.40) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.40). Learn more on analysts' earnings estimate vs. VOR's actual earnings.

Vor Biopharma's earnings are expected to grow from ($1.42) per share to ($1.03) per share in the next year.

More Earnings Resources from MarketBeat



This page (NYSE:VOR) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners